3 August 2018, Hill+Knowlton Strategies (H+K) has appointed Helen Gan to a newly created role of China Healthcare Practice Leader. With over 15 years of PR and marketing communications experience in China and the Asia-Pacific region, Helen has a proven track record in leading client service teams across leading international pharmaceutical companies.
Helen’s experience includes market access programs, stakeholder engagement, charity programs and patient and professional marketing for clients including, AstraZeneca, Takeda, Sanofi, MSD, Roche, UCB and Cstone.
QC Liang, President and CEO, H+K China, comments, “H+K China has been going from strength to strength in the healthcare space and now it’s the right time to establish a dedicated centre of excellence under the strategic leadership of Helen. Driven by the Chinese government’s “Healthy China 2030” blueprint pledging to build a healthy China in the next 12 years, we are seeing tremendous opportunities in the health sector – from pharmaceuticals to medical devices and private healthcare services. Helen’s extensive sector experience will ensure H+K can partner with these clients at a deeper level to help them achieve growth and support the government’s vision.”
Helen will head up the healthcare practice out of H+K’s Shanghai office, serving clients across H+K offices in mainland China (Beijing, Shanghai, Guangzhou, Shenzhen) and Hong Kong.
For Media Enquiries:
Business Development + Marketing, China
+86 21 2287 1837
About Hill+Knowlton Strategies
Hill+Knowlton Strategies, Inc. is an international communications consultancy, providing services to local, multinational, and global clients. The firm is headquartered in New York, with more than 85 offices in 47 countries, as well as an extensive associate network. The agency is part of WPP, one of the world’s largest communications services groups.